[
  {
    "ts": "2026-01-09T13:00:00+00:00",
    "headline": "Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models",
    "summary": "WALTHAM, Mass., January 09, 2026--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.",
    "url": "https://finance.yahoo.com/news/revvity-collaborates-lilly-expand-access-130000963.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a2d177a0-e1b1-3ffb-9dfd-e5e5d9ddfbb7",
      "content": {
        "id": "a2d177a0-e1b1-3ffb-9dfd-e5e5d9ddfbb7",
        "contentType": "STORY",
        "title": "Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models",
        "description": "",
        "summary": "WALTHAM, Mass., January 09, 2026--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.",
        "pubDate": "2026-01-09T13:00:00Z",
        "displayTime": "2026-01-09T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/36d5cdf9ed3c61a49a27a967eaf73629",
          "originalWidth": 784,
          "originalHeight": 320,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VIAQmKPhUw0Tb0iso8v4nQ--~B/aD0zMjA7dz03ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/36d5cdf9ed3c61a49a27a967eaf73629.cf.webp",
              "width": 784,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Pv.KuW5Yu2ZKaJQlz5Jjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/36d5cdf9ed3c61a49a27a967eaf73629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revvity-collaborates-lilly-expand-access-130000963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revvity-collaborates-lilly-expand-access-130000963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]